Zastosowanie kolagenu w technologii postaci leku : osiągnięcia i perspektywy

• Autorzy: Turek A. , Kasperczyk J. , Dzierżewicz Z.

Warianty tytułu

EN

Collagen application In drug formulation technology : achievements and perspectives

• Języki publikacji: PL

Abstrakty

PL

Kolagen należy do dobrze poznanych biopolimerów. Przeprowadzone badania jego właściwości predysponują go do zastosowania w szeroko pojętym przemyśle biomedycznym. Poszukiwania nowych rozwiązań w technologii postaci leku dotyczących kontrolowanego i przedłużonego uwalniania leków spowodowało zastosowanie kolagenu, jako nośnika substancji leczniczych. Do najczęściej stosowanych postaci leków opartych na białkach kolagenowych należą gąbki i osłony kolagenowe. Prowadzone badania nad innowacyjnymi postaciami leków pozwolą na wprowadzenie szeregu nowych rozwiązań wykorzystujących kolagen jako nośnik substancji leczniczej.

EN

Collagen belongs to the well-known biopolymers. Developing of its properties has shown that it can be used in the biomedical industry. Studies on novel solutions in drug formulation technology for controlled and prolonged drug release has led to the application of collagen as a drug carrier. Among the most commonly used collagen-based drug formulations are sponges and collagen shields. Studies on innovative drug formulations will enable introduction of a range of novel solutions which use collagen as a drug carrier.

Słowa kluczowe

PL

kolagen; nośnik substancji leczniczych; postacie innowacyjne leków

EN

collagen; drug carriers; innovative drug formulations

• Wydawca: Stowarzyszenie Inżynierów i Techników Przemysłu Chemicznego, ZW CHEMPRESS-SITPChem
• Czasopismo: Chemik
• Rocznik: 2010
• Tom: Vol. 64, nr 4
• Strony: 229--237
• Opis fizyczny: Bibliogr. 56 poz., 5 rys.

Twórcy

autor

Turek A.

autor

Kasperczyk J.

autor

Dzierżewicz Z.

• Katedra i Zakład Biofarmacji, Śląski Uniwersytet Medyczny, Sosnowiec

Bibliografia

• 1. Bloomfield S.E., Miyata T., Dunn M.W., Bueser N., Stenzel K.H., Rubin A.L.:Soluble gentamycin ophthalmic inserts as a drug delivery system. Arch. Ophthalmol 1978, 96, 885.
• 2. Siegel S.J., Winey K.I., Gur R.E., Lenox R.H., Bilker W.B., Ikeda D., Gandhi N., Zhang W.X.: Surgically implantable long-term antipsychotic delivery systems for the treatment of schizophrenia. Neuropsychopharmacology 2002, 26,817.
• 3. Kasperczyk J., Stokłosa K., Dobrzynski R, Stepien K., Kaczmarczyk B., Dzierzega-Lecznar A.: Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy. Int. J. Pharm., 2009, 382, 124.
• 4. Chvapil M., Chvapil T.A., Owen J.A: Reaction of various skin wounds in the rat to collagen sponge dressing. J. Surg. Res., 1986, 41,410.
• 5. Wedge C. I., Rootman D.S.: Collagen shields: efficacy, safety and comfort in the treatment of human traumatic corneal abrasion and effect on vision in healthy eyes. Can. J. Ophthalmol. 1992, 27, 295.
• 6. Jenkins C.L., Raines R.T.: Insight on the conformational stability of collagen. Nat. Prod. Rep. 2002, 19, 49.
• 7. Gelse K., Pöschl E., Aigner T.: Collagens - structure, functions, and biosynthesis. Adv. Drug. Deliv. Rev. 2003, 55, 1531.
• 8. Ploetz E., Zycband E.I., Brik D.E.: Collagen fibril assembly and deposition in the developing dermis: segmental deposition in extracellular compartments. J. Struct. Biol. 1991, 106, 73.
• 9. Jastrzębska M., Barwinski B., Mroz I.,Turek A.,Zalewska-Rejdak J.,Cwalina B.: Atomic force microscopy investigation of chemically stabilized pericardium tissue. Eur. Phys. J. E Soft Matter. 2005, 16, 381.
• 10. Turek A., Marcinkowski A., Trzebicka B., Cwalina B., Dzierżewicz Z.: Nanostructure of bovine pericardium treated with trypsin. Eng. Biomater. 2009, 89-91, 30.
• 11. Yamauchi M., Mechanic G.: Cross-linking of collagen. W: Nimni ME (red.). Collagen. Vol. I., Boca Raton, CRC Press 1988, 157.
• 12. Jerome A., Ramshaw J.A.: Editorial: collagen-based. Biomaterials 1992, 9, 137.
• 13. Rao K.P.: Recent developments of collagen-based materials for medical applications and drug delivery systems. J. Biomater. Sci. Polym. Ed. 1995, 7, 623.
• 14. Friess W.: Collagen-biomaterial for drug delivery. Eur. J. Pharm. Biopharm. 1998,45, 113.
• 15. Fujioka K., Maeda M., Hojo T., Sano A.: Protein release from collagen matrices. Adv. Drug. Del. Rev. 1998, 31, 247.
• 16. Gorham S.D.: Collagen. W: Byrom D. (red.), Biomaterials, Stockton Press, New York 1991, 55-122.
• 17. Doillon C. J., Whyne C.F., Brandwein S., Silver F.H.: Collagen based wound dressings: control of pore structure and morphology. J. Biomed. Mater. Res. 1986, 20, 1219.
• 18. Strates B., Neuman W.F.: On the mechanisms of calcification. Proc. Soc. Exp. Biol. Med. 1958, 97, 688.
• 19. Weiner A.L., Carpenter-Green S.S., Soehngen E.C., Lenk R.P., Popescu M.C.: Liposome-collagen gel matrix: a novel sustained drug delivery system. J. Pharm. Sci. 1985,74, 922.
• 20. Wenz B., Oesch B., Host M.: Analysis of the risk of transmitting bovine spongiform encephalopathy through bone grafts derived from bovine bone. Biomaterials 2001, 22, 1599.
• 21. Reidy J.J., Gebhardt B.M., Kaufman H.E.: The collagen shield. Anew vehicle for delivery of cyclosporin A to the eye. Cornea 1990, 9, 196.
• 22. Wachol-Drewek Z., Pfeiffer M., Scholl E.: Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and a sponge containing gentamicin. Biomaterials 1996, 17, 1733.
• 23. Ruszczak Z., Friess W.: Collagen as a carrier for on-site delivery of antibacterial drugs. Adv. Drug Deliv. Rev. 2003, 55, 1679.
• 24. Khor E.: Methods for the treatment of collagenous tissue for bioprosheses. Biomaterials 1997, 18, 95.
• 25. Schmidt C.E., Baier J.M.: Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000, 21, 2215.
• 26. Moore M.A.: PhotoFix: unraveling the mystery. J. Long Term Eff. Med. Implants 2001, 11, 185.
• 27. Jayakrishnan A., Jameela S.R.: Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. Biomaterials 1996, 17, 417.
• 28. Weadock K.S., Miller E.J., Bellincampi L.D., Zawadsky J.P., Dunn M.G.: Physical crosslinking of collagen fibers: comparison of ultraviolet irradiation and dehydrothermal treatment. J. Biomed. Mater. Res. 1995, 29, 1373.
• 29. Thoma R.J., Phillips R.E.: The role of material surface chemistry in implant device calcification: a hypothesis. J. Heart Valve Dis., 1995, 4, 214.
• 30. Gendler E., Gendler S., Nimni M.E.: Toxic reactions evoked by glutaraldehyde - fixed pericardium and cardiac valve tissue bioprosthesis. J. Biomed. Mater. Res. 1984, 18, 727.
• 31. Fujimori E.: Ultraviolet light-induced change in collagen macromolecules. Bi-opolymers 1965, 3, 115.
• 32. Cooper D.R., Davidson R.J.: The effect of ultraviolet irradiation on collagen-fold formation. Biochem. J. 1966, 98, 655.
• 33. Mcllroy B.K., Robinson M.D., Chen W.M., Moore M.A.: Chemical modification of bovine tissues by dye-mediated photooxidation. J. Heart Valve Dis. 1997, 6,416.
• 34. Spikes J.D., Shen H.R., Kopeckova P., Kopecek J.: Photodynamic cross-linking of proteins. III. Kinetic of the FMN-and rose bengal-sensitized photooxidation and intermodular crosslinking of model tyrosine-containing N-(2-hydroxypropyl)methacylamide copolymers. Photochem. Photobiol. 1999, 70, 130.
• 35. Yannas I.V, Tobolsky A.V.: Cross-linking of gelatine by dehydration. Nature 1967, 215, 509.
• 36. Wang M.C., Pins G.D., Silver F.H.: Collagen fibres with improved strength for the repair of soft tissue injuries. Biomaterials 1994, 5, 507.
• 37. Ma X.H., Noishiki Y., Yamane Y., Iwai Y., Marato D., Matsumoto A.: Thermal cross-linking for biologically degradable materials. ASAIO J. 1996, 42, M866.
• 38. Rubin A.L., Stenzel K.H., Miyata T., White M.J., Dunn M.: Collagen as a vehicle for drug delivery. Preliminary report. J. Clin. Pharmacol. 1973, 13, 309.
• 39. Friedberg M.L., Pleyer U., Mondino B.J.: Device drug delivery to the eye. Ophthalmology 1991,98, 725.
• 40. Mondino B.J.: Collagen shields. Am. J. Ophthalmol. 1991, 112, 587.
• 41. Kaufman H.E., Steinemann T.L., Lehman E., Thompson H.W., Varnell E.D., Jacob-La Barre J.T., Gerbhardt B.M.: Collagen based drug delivery and artificial tears. J. Ocul. Pharmacol. 1994, 10, 17.
• 42. Gebhardt B.M., Varnell E.D., Kaufman H.E.: Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection. J. Ocul. Pharmacol. Ther. 1995, 11, 509.
• 43. Lee C.H., Singla A., Lee Y.: Biomedical applications of collagen. Int. J. Pharm.
• 44. Matarasso S.L., Beer K.: Preparaty kolagenu do wstrzykiwania. W: Carruthers J., Carruthers A. (red.): Metody wypełniania tkanek miękkich stosowane w kosmetologii. Wydawnictwo Medyczne Urban i Partner, Wrocław 2006, 21-34.
• 45. Miller B.H., Shavin J.S., Cognetta A., Taylor R.J., Salasche S., Korey A., Orenberg E.K.: Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel. J. Am. Acad. Dermatol. 1997, 36, 72.
• 46. Minabe M., Takeuchi K., Tamura K., Hori T., Umemoto, T.: Subgingival administration of tetracycline on a collagen film. J. Periodontol. 1989, 60, 552.
• 47. Chen M.C., Liang H.F., Chiu Y.L., Chang Y., Wei H.J., Sung H.W.: A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus. J. Control. Release 2005, 108, 178.
• 48. Harrison K.W.: Collagen corneal shields - an important therapeutic modality. J. Ophthal. Nurs. Technol. 1989, 8, 97.
• 49. Robin J.B., Keys C.L., Kamiński L.A., Viana M.A.: The effect of collagen shields on rabbit corneal re-epithelization after chemical debridement. Invest. Ophthalmol. Vis. Sci. 1990,31, 1294.
• 50. Marmer R.H.: Therapeutic and protective properties of the corneal shield. J. Cataract Refract. Surg. 1988, 14, 496.
• 51.Kaufman H.E.: Collagen shield symposium. J. Cataract Refract. Surg. 1988, 14, 487.
• 52. Phinney R.B., Schwartz S.D., Lee D.A., Mondino B.J.: Collagen shield delivery of gentamicin and vancomycin. Arch. Ophthalmol. 1988, 106, 1599.
• 53. Geiger M., Friess W.: Collagen sponge implants-applications, characteristics and evaluation: Part I: Pharm. Tech. Europe 2002, 14, 48.
• 54. Pachence J.M., Berg R.A., Silver F.H.: Collagen: its place in the medical device industry. Med. Dev. Diagn. Ind. 1987, 9, 49.
• 55. Yannas I.V.: Biologically active analogues of the extracellular matrix: artificial skin and nerves. Angew. Chem. Int. Ed. 1990, 29, 20.
• 56. Stemberger A., Grimm H., Bader F., Rahn H.D., Ascherl R.: Local treatment of bone and soft tissue infections with the collagen gentamicin sponge. Eur. J.Surg. 1997, 578 (Suppl 163), 17.